Tool offers increased precision in estimating exacerbation risk Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. It is frequently seen in primary ...
Patients with both chronic obstructive pulmonary disease (COPD) and severe pain are at an almost 40% predicted probability of falling, indicating the potential interaction between the conditions.
Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated. Among ...
Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities.
Noninvasive ventilation is a well-known life-sparing option during acute exacerbations of chronic obstructive pulmonary disease (COPD), but its effectiveness for severe, but stable disease has been ...
Integrated primary care services may offer better outcomes in patients living with severe chronic obstructive pulmonary disease (COPD) without increasing costs. The integrated primary care ...
In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully ...
Nutrition is more than just calories, carbohydrates and protein; it can be a powerful tool in managing lung disease and ...
The decades-long practice of prescribing long-term oxygen for 24 hours a day to patients with severe hypoxemia from chronic lung diseases appears unnecessary, according to findings from a randomized ...
Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...
Some patients with chronic obstructive pulmonary disease, or COPD, are breathing easier thanks to new technology in the form of a small valve inserted in the lung. Paula Dote had the Zephyr valves ...